Lucira Health now has the first FDA authorized diagnostic that detects the novel coronavirus and influenza in a single test. But the regulatory decision comes too late for the diagnostics developer, which has filed for bankruptcy protection.
A webinar sponsored by BD scheduled for March 7 will explore how diagnostics companies are working with healthcare organizations to guard against the perfect storm of Covid-19, RSV and influenza.
Sofia Guerra, Investor, Bessemer Venture Partnersand
Harry Glorikian, General Partner, Scientia Ventures
There is no fee to apply. Only companies funded from 2018-2022, and that have raised a seed funding round will be considered. Application Deadline: February 28, 2023. Selections will be announced on March 22, 2023.
Wearable patient devices can provide healthcare organizations with more varied data, expand options for clinical trials, and make patients more active participants in their own care.
Creating a category for technologies like the safety release valve would confer benefits, including improved patient safety, reduced costs for the healthcare system overall, and lowered liability risk.
Homeward will be serving BCBS Minnesota's Medicare Advantage members in 24 counties. The company provides primary and specialty care in the home, virtually and in the community through mobile clinics. It leverages cellular-based remote monitoring to track patients' health in-between visits. The company also partners with existing providers in the area for this care.
Learn how an AI-powered solution helped Blue Cross Blue Shield of Rhode Island target members within its congestive heart failure (CHF) and spinal care (MSK) programs to identify avoidable hospitalizations and drive significant cost savings.
No comments